Skip to content
OpenCapital
Get started

Acadia Pharmaceuticals ACAD Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATX logo
GATXGATX
$1.75M+243%
CarGurus, Inc. logo
CarGurus, Inc.CARG
-$613K-186%
Seaboard logo
SeaboardSEB
$0-100%
HTF
Heartflow, Inc. Common StockHTFL
26,200,000%+17,776,022pp
Repligen logo
RepligenRGEN
-$145K-104%
FTI Consulting logo
FTI ConsultingFCN
-$4.67M-179%

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M—
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.87B+37.0%

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%—

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0×0.0×
Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
Acadia Pharmaceuticals (ACAD) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of $25K in Q1 2026.
How has Acadia Pharmaceuticals's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
Acadia Pharmaceuticals's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash increased by 600.0% year-over-year, from -$5K to $25K.
What is the long-term trend for Acadia Pharmaceuticals's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
Over 2 years (2023 to 2025), Acadia Pharmaceuticals's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash has grown at a 20.2% compound annual growth rate (CAGR), from -$18K to $26K.